Phoa, A.F.; Recasens, A.; Gurgis, F.M.S.; Betts, T.A.; Menezes, S.V.; Chau, D.; Nordfors, K.; Haapasalo, J.; Haapasalo, H.; Johns, T.G.;
et al. MK2 Inhibition Induces p53-Dependent Senescence in Glioblastoma Cells. Cancers 2020, 12, 654.
https://doi.org/10.3390/cancers12030654
AMA Style
Phoa AF, Recasens A, Gurgis FMS, Betts TA, Menezes SV, Chau D, Nordfors K, Haapasalo J, Haapasalo H, Johns TG,
et al. MK2 Inhibition Induces p53-Dependent Senescence in Glioblastoma Cells. Cancers. 2020; 12(3):654.
https://doi.org/10.3390/cancers12030654
Chicago/Turabian Style
Phoa, Athena F., Ariadna Recasens, Fadi M. S. Gurgis, Tara A. Betts, Sharleen V. Menezes, Diep Chau, Kristiina Nordfors, Joonas Haapasalo, Hannu Haapasalo, Terrance G. Johns,
and et al. 2020. "MK2 Inhibition Induces p53-Dependent Senescence in Glioblastoma Cells" Cancers 12, no. 3: 654.
https://doi.org/10.3390/cancers12030654
APA Style
Phoa, A. F., Recasens, A., Gurgis, F. M. S., Betts, T. A., Menezes, S. V., Chau, D., Nordfors, K., Haapasalo, J., Haapasalo, H., Johns, T. G., Stringer, B. W., Day, B. W., Buckland, M. E., Lalaoui, N., & Munoz, L.
(2020). MK2 Inhibition Induces p53-Dependent Senescence in Glioblastoma Cells. Cancers, 12(3), 654.
https://doi.org/10.3390/cancers12030654